Genus plc (OTCMKTS:GENSF – Get Free Report) was the target of a large growth in short interest in January. As of January 30th, there was short interest totaling 37,249 shares, a growth of 633.5% from the January 15th total of 5,078 shares. Based on an average trading volume of 60 shares, the short-interest ratio is currently 620.8 days. Based on an average trading volume of 60 shares, the short-interest ratio is currently 620.8 days.
Wall Street Analysts Forecast Growth
Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Genus in a research report on Thursday, November 20th. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock has an average rating of “Buy”.
Get Our Latest Stock Report on Genus
Genus Price Performance
Genus Company Profile
Genus plc, trading on the OTCMKTS under the symbol GENSF, is a global leader in innovative animal genetics and breeding solutions. The company operates through two primary business segments: ABS and PIC. ABS focuses on bovine genetics, offering dairy and beef cattle semen, advanced reproductive technologies and digital herd management tools. PIC specializes in porcine genetics, providing breeding stock, genetic evaluation services and production support aimed at optimizing growth performance, health and sustainability across the global swine industry.
With origins dating back to its establishment in 1933 as the British Dairy Cattle Breeders’ Society, Genus has expanded through strategic acquisitions and organic growth to build a leading position in animal biotechnology.
Featured Articles
- Five stocks we like better than Genus
- Is THIS the Next Big Money Rush?
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
- They just tried to kill gold
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
